JAN 05, 2021 1:56 PM PST

Two gene expression subtypes identified in peritoneal carcinomatosis cells

New research published in Nature Medicine finds two subtypes of gene expression in peritoneal carcinomatosis (PC) that correlate with patient survival. PC is a kind of metastatic gastric cancer in the peritoneal (abdominal) cavity. The research comes from scientists at The University of Texas MD Anderson Cancer Center.

PC occurs when cancer cells spread to the peritoneal cavity and attach to the stomach and other organs, resulting in fluid accumulation; unfortunately, patients have an overall survival of fewer than six months.

"PC represents a major unmet clinical need, as we don't have effective treatment options available for these patients," said co-corresponding author Jaffer Ajani, M.D., professor of Gastrointestinal Medical Oncology. "Based on our findings, we need to move toward profiling these cells in each patient in order to offer more tailored treatment options."

In carrying out the study, the researchers analyzed over 45,000 individual cells from patients with PC. This in-depth analysis is the most extensive that has been conducted.

"In order to better treat patients with PC, we first have to understand the populations of metastatic cells in the peritoneal cavity," said co-corresponding author Linghua Wang, M.D., Ph.D., assistant professor of Genomic Medicine. "This is the most detailed analysis of these cells performed to date. That is the power of single-cell analysis -- we are able to look at every single cell and get a picture of the landscape."

In their analysis of the cells, the team noticed a clear distinction between two different types of cells and their correlations with survival. Wang explains: "The intriguing aspect is that, by classifying tumor cells based on lineage compositions, we noted two groups of patients. The more gastric-like PC cells had an aggressive phenotype and were associated with shorter survival. However, the more intestine-like PC cells were less aggressive, and patients had longer survival."

Photo: Pixabay

Based on this information, the researchers were able to develop a gene expression signature that allows for a more accurate prediction of patient survival than current tools. The team says they hope that their findings can be used to guide treatment decision-making processes.

Sources: Nature Medicine, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
DEC 28, 2020
Cancer
Revealing a Critical Protein Involved in the Pentose Phosphate Pathway in Cancer
DEC 28, 2020
Revealing a Critical Protein Involved in the Pentose Phosphate Pathway in Cancer
The metabolism of cancer has interested scientists in recent decades. Many cancers conduct "normal" metabolism ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
Loading Comments...